Novel pathophysiological role of classical chemotactic peptide receptors and their communications with chemokine receptors

Immunological Reviews

Volumn 177, Issue , 2000, Pages 185-194

  Le, Yingying ^a,b   Li, Baoqun ^b   Gong, Wanghua ^b   Shen, Weiping ^a,b   Hu, Jinyue ^a,b   Dunlop, Nancy M ^a,b   Oppenheim, Joost J ^a,b   Wang, Ji Ming ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; FORMYLMETHIONYLLEUCYLPHENYLALANINE; FORMYLPEPTIDE; G PROTEIN COUPLED RECEPTOR;

BINDING AFFINITY; CELL ACTIVATION; CHEMOTAXIS; DESENSITIZATION; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; PHAGOCYTOSIS; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW;

EID: 0033659692     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2000.17704.x     Document Type: Review

References (101)

1. Chemoattractant stimulus-response coupling
2. Complement: Biologically active products
3. Specific receptors of platelet-activation factor, receptor heterogeneity, and signal transduction mechanisms
4. Properties of the novel pro-inflammatory supergene 'intercrine' cytokine family
5. Chemokines
6. Recent advances in chemokines and chemokine receptors
7. Human macrophage inflammatory protein α (MIP-1α) and MIP-1β chemokines attract distinct populations of lymphocytes
8. + T cells in response to MIP-1α and MIP-1β
9. Platelet factor 4: Production, structure, and physiologic and immunologic action
10. Demonstration of stem cell inhibition and myeloprotective effects of SCI/rhMIP1α in vivo
11. Interleukin-8 as a macrophage-derived mediator of angiogenesis
12. RANTES and macrophage inflammmatory protein 1α induce the migration and activation of normal human eosinophil granulocytes
13. Chemokines, receptors, and their role in cardiovascular pathology
14. Inhibition of angiogenesis by recombinant platelet factor 4 and related peptides
15. Chemokines and their role in tumor growth and metastasis
16. Chemoattractant receptor cross-desensitization
17. HIV-1 gp41 is a potent inhibitor of chemoattractant receptor expression and function in monocytes
18. HIV-1 envelope gp120 inhibits monocyte response to chemokines through CD4 signal-dependent chemokine receptor down-regulation
19. T20/DP178, an ectodomain peptide of human immunodeficiency virus type 1 gp41, is an activator of human phagocyte N-formyl peptide receptor
20. T21/DP107, a synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G protein-coupled formyl peptide receptors
21. A synthetic peptide derived from HIV-1 gp120 down-regulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the seven-transmembrane G protein-coupled receptor FPRL1/LXA4R
22. Serum amyloid A is a chemoattractant: Induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes
23. Serum amyloid A induces calcium mobilization and chemotaxis of human monocytes by activating a pertussis toxin-sensitive signaling pathway
24. A seven-transmembrane, G-protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells
25. N-formylmethionyl peptides as chemoattractants for leucocytes
26. The isolation and partial characterization of neutrophil chemotactic factors from Escherichia coli
27. Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli
28. Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils
29. 125I-chemotactic peptide by human neutrophils
30. Covalent affinity labeling of the formyl peptide chemotactic receptor
31. Synthesis and use of a novel N-formyl peptide derivative to isolate a human N-formyl peptide receptor cDNA
32. The human N-formylpeptide receptor. Characterization of two cDNA isolates and evidence for a new subfamily of G-protein-coupled receptors
33. Cloning of the gene coding for the human receptor for formyl peptides: Characterization of a promoter region and evidence for polymorphic expression
34. Sequence and organization of the human N-formyl peptide receptor-encoding gene
35. Structure, 5'-flanking sequence, and chromosome location of the human N-formyl peptide receptor gene. A single-copy gene comprised of two exons on chromosome 19q.13.3 that yields two distinct transcripts by alternative polyadenylation
36. Functional expression of the human formyl peptide receptor in Xenopus oocytes requires a complementary human factor
37. Regulation of formyl peptide receptor expression and its mRNA levels during differentiation of HL-60 cells
38. N-formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation
39. Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines
40. Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia
41. FMLP actions and its binding sites in isolated human coronary arteries
42. Broad immunocytochemical localization of the formylpeptide receptor in human organs, tissues and cells
43. Molecular evolution of the N-formyl peptide and C5a receptors in non-human primates
44. Molecular cloning of the fMet-Leu-Phe receptor from neutrophils
45. The rabbit neutrophil N-formyl peptide receptor, cDNA cloning, expression, and structure/function implications
46. Species and subtype variants of the N-formyl peptide chemotactic receptor reveal multiple important functional domains
47. A structural homologue of the N-formyl peptide receptor. Characterization and chromosome mapping of a peptide chemoattractant receptor family
48. Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor
49. Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homologue orphan receptors (FPRH1, FPRH2) to chromosome 19
50. Multiple domains of the N-formyl peptide receptor are required for high-affinity ligand binding. Construction and analysis of chimeric N-formyl peptide receptors
51. Differential expression of members of the N-formylpeptide receptor gene cluster in human phagocytes
52. Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon γ and inhibits tumor necrosis factor α-induced IL-8 release
53. The N-formyl peptide receptor: A model for the study of chemoattractant receptor structure and function
54. Differential expansion of the N-formylpeptide receptor gene cluster in human and mouse
55. N-formylpeptides induce two distinct concentration optima for mouse neutrophil chemotaxis by differential interaction with two N-formylpeptide receptor (FPR) subtypes: Molecular characterization of FPR2, a second mouse neutrophil FPR
56. Formyl peptide chemoattractants: A model of the receptor on rabbit neutrophils
57. The N-formyl peptide chemotactic receptors
58. A high potency nonformylated peptide agonist for the phagocyte N-formylpeptide chemotactic receptor
59. N-terminus urea-substituted chemotactic peptides: New potent agonists and antagonists toward the neutrophil fMLF receptor
60. Selective inhibition of N-formylpeptide-induced neutrophil activation by carbamate-modified peptide analogues
61. A peptide with unique receptor specificity. Stimulation of phosphoinositide hydrolysis and induction of superoxide generation in human neutrophils
62. Distribution of the receptor for a novel peptide stimulating phosphoinositide hydrolysis in human leukocytes
63. Trp-Lys-Tyr-Met-Val-D-Met stimulates superoxide generation and killing of Staphylococcus aureus via phospholipase D activation in human monocytes
64. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation
65. Identification of surrogate agonists for the human FPRL-1 receptor by autocrine selection in yeast
66. Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis
67. A novel biologic function of serum amyloid A. Induction of T lymphocyte migration and adhesion
68. Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor
69. 2+ mobilization
70. Leukotrienes and lipoxins: Structures, biosynthesis, and biological effects
71. Inhibition of leukotriene B4-induced neutrophil migration by lipoxin A4: Structure-function relationships
72. Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers
73. Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor
74. Phagocytic cells: Stimulus-response coupling mechanisms
75. Differences in phosphorylation of formylpeptide and C5a chemoattractant receptors correlated with differences in desensitization
76. Chemoattractant receptors activate distinct pathways for chemotaxis and secretion. Role of G-protein usage
77. Two distinct Gi-proteins mediate formyl peptide receptor signal transduction in human leukemia (HL-60) cells
78. Differential activation of dibutyryl cAMP-differentiated HL-60 human leukemia cells by chemoattractants
79. Quantitative analysis of formyl peptide receptor couping to Giα1, Giα2, and Giα3
80. Isozyme-selective stimulation of phospholipase C-β2 by G protein βγ-subunits
81. Stimulation of human neutrophils with fMLP induces tyrosine phosphorylation and activation of two distinct mitogen-activated protein kinase
82. Formyl peptide receptors are coupled to multiple mitogen-activated protein kinase cascades by distinct signal transduction pathways: Role in activation of reduced nicotinamide adenine dinucleotide oxidase
83. Gβγ stimulates phosphoinositide 3-kinase-γ by direct interaction with two domains of the catalytic p110 subunit
84. fMet-Leu-Phe stimulates proinflammatory cytokine gene expression in human peripheral blood monocytes: The role of phosphatidylinositol 3-kinase
85. G protein-coupled chemoattractant receptors regulate lyn tyrosine kinase-Shc adapter protein signaling complexes
86. Differential coupling of the formyl peptide receptor to adenylate cyclase and phospholipase C by the pertussis toxin-insensitive Gz protein
87. High constitutive activity of the human formyl peptide receptor
88. Impaired antibacterial host defense in mice lacking the N-formylpeptide receptor
89. Decline of anti-DP107 antibody associated with clinical progression
90. The acute-phase response
91. Serum amyloid A (SAA), a protein without a function: Some suggestions with reference to cholesterol metabolism
92. Protein AA/SAA
93. Human serum amyloid A (SAA) protein: A prominent acute-phase reactant for clinical practice
94. Expression and regulation of constitutive and acute phase serum amyloid A mRNAs in hepatic and non-hepatic cell lines
95. Recombinant human serum amyloid A (apoSAAp) binds cholesterol and modulates cholesterol flux
96. Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins
97. Inflammatory mechanisms in Alzheimer disease: The role of β amyloid/glial interactions
98. Microglia and Alzheimer's disease
99. Differential effects of CC chemokines on CC chemokine receptor 5 (CCR5) phosphorylation and identification of phosphorylation sites on the CCR5 carboxyl terminus
100. Chemokine-induced phosphorylation of CC chemokine receptor 5 (CCR5)
101. Molecular mechanism of desensitization of the chemokine receptor CCR-5: Receptor signaling and internalization are dissociable from its role as an HIV-1 co-receptor